Member of the Association of American Physicians
His primary areas of study are Cancer research, Genetics, Mutation, Gene and Colorectal cancer. He has included themes like Carcinogenesis, Cancer, DNA methylation, Molecular biology and Signal transduction in his Cancer research study. His Cancer research integrates issues from Cell, Cell signaling, Immunology, Germline and Pathology.
His Mutation study integrates concerns from other disciplines, such as Transforming growth factor, Cell culture, Microsatellite instability and DNA repair. His DNA mismatch repair, Coding region, Wild type and Gene mutation study in the realm of Gene connects with subjects such as P110δ. His work focuses on many connections between Colorectal cancer and other disciplines, such as Methylation, that overlap with his field of interest in Vimentin.
His scientific interests lie mostly in Cancer research, Colorectal cancer, Internal medicine, Cancer and Genetics. His work deals with themes such as Carcinogenesis, Tumor suppressor gene, Mutation, Microsatellite instability and Pathology, which intersect with Cancer research. His Mutation research includes themes of DNA repair and Somatic cell.
His Colorectal cancer research incorporates themes from Biomarker, Molecular biology and Adenoma. He has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study. His work carried out in the field of Cancer brings together such families of science as Immunology and Germline.
Colorectal cancer, Internal medicine, Cancer research, Oncology and Cancer are his primary areas of study. His work in Colorectal cancer addresses subjects such as Genome-wide association study, which are connected to disciplines such as Genetic association, Primary tumor and Carcinogenesis. His study focuses on the intersection of Internal medicine and fields such as Gastroenterology with connections in the field of Prospective cohort study, Celecoxib and Methylation.
His Cancer research study which covers Spleen that intersects with Regeneration. His Oncology research is multidisciplinary, incorporating elements of Esophagus, Genetic risk and Early detection. The Barrett's esophagus study combines topics in areas such as Epithelium, Pathology, Genetically modified mouse and Molecular biology.
Sanford D. Markowitz focuses on Colorectal cancer, Internal medicine, Cancer research, Adenoma and Gastroenterology. His Colorectal cancer research includes themes of Genome-wide association study, Indel, Case-control study, Wild type and Genotype. The concepts of his Case-control study study are interwoven with issues in Genetics, Allele, Allele frequency and Genetic predisposition.
His work is dedicated to discovering how Internal medicine, Oncology are connected with Breast cancer, Confidence interval, Mendelian Randomization Analysis, Odds ratio and Epidemiology of cancer and other disciplines. Sanford D. Markowitz has researched Cancer research in several fields, including Cell growth, Gene knockdown, Transcriptome, Glutamine and In vivo. In his research, Clinical trial and Receiver operating characteristic is intimately related to Colonoscopy, which falls under the overarching field of Adenoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
High frequency of mutations of the PIK3CA gene in human cancers
Yardena Samuels;Zhenghe Wang;Alberto Bardelli;Natalie Silliman.
Science (2004)
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Sanford D Markowitz;Jing Wang;Lois Myeroff;Ramon Parsons.
Science (1995)
Suppression of human colorectal carcinoma cell growth by wild-type p53.
Suzanne J. Baker;Sanford D Markowitz;Eric R. Fearon;James K V Willson.
Science (1990)
Molecular Basis of Colorectal Cancer
Sanford D. Markowitz;Monica M. Bertagnolli.
The New England Journal of Medicine (2009)
Mutations of mitotic checkpoint genes in human cancers
Daniel P. Cahill;Christoph Lengauer;Jian Yu;Gregory J. Riggins.
Nature (1998)
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
Suzanne J. Baker;Antonette C. Preisinger;J. M. Jessup;Christos Paraskeva.
Cancer Research (1990)
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
G. S. Wu;T. F. Burns;E. R. McDonald;W. Jiang.
Nature Genetics (1997)
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Hiromu Suzuki;Hiromu Suzuki;D. Neil Watkins;Kam Wing Jair;Kornel E. Schuebel.
Nature Genetics (2004)
Somatic mutations of the mitochondrial genome in human colorectal tumours
Kornelia Polyak;Kornelia Polyak;Yunbo Li;Hong Zhu;Christoph Lengauer.
Nature Genetics (1998)
Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
Ramon Parsons;Lois L. Myeroff;Bo Liu;James K. V. Willson.
Cancer Research (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Case Western Reserve University
Johns Hopkins University
Case Western Reserve University
University of North Carolina at Chapel Hill
Johns Hopkins University
Memorial Sloan Kettering Cancer Center
Johns Hopkins University School of Medicine
Case Western Reserve University
German Cancer Research Center
TU Dresden
Sapienza University of Rome
Pennsylvania State University
University of Akron
Indian Institute of Technology Kharagpur
South China University of Technology
Murdoch University
University of Duisburg-Essen
Cincinnati Children's Hospital Medical Center
University of Michigan–Ann Arbor
Karlsruhe Institute of Technology
Karolinska Institute
University of Haifa
Harvard University
Istituto Giannina Gaslini
Northwestern University